Terms: = Uterine cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Diagnosis
254 results:
1. Interventions to increase follow-up of abnormal cervical cancer screening results: A systematic literature review and meta-analysis.
Varon ML; Geng Y; Fellman BM; Troisi C; Fernandez ME; Li R; Reininger B; Schmeler KM; Allanson E
PLoS One; 2024; 19(2):e0291931. PubMed ID: 38381754
[TBL] [Abstract] [Full Text] [Related]
2. Gynaecological follow-up for women of reproductive age with multiple sclerosis: The GYNESEP study.
Renaud J; Buissonnière P; Dulau C; Deloire M; Hontarrede F; Montcuquet A; Chansel-Debordeaux L; Hocké C; Ouallet JC; Ruet A; Bernard V
Mult Scler Relat Disord; 2024 Mar; 83():105448. PubMed ID: 38277979
[TBL] [Abstract] [Full Text] [Related]
3. Reduced healthcare access contributes to delay of care in endometrial cancer.
Fife AJ; Najor AJ; Aspir TB; Haines KE; Vilardo NA; Isani SS; Cowan M; Gressel GM; Ye KQ; Nevadunsky NS; Kuo DY; Lin KY
Gynecol Oncol; 2024 Mar; 182():115-120. PubMed ID: 38262233
[TBL] [Abstract] [Full Text] [Related]
4. Lymphedema self-assessment among endometrial cancer survivors.
Brown JA; Olshan AF; Bae-Jump VL; Ogunleye AA; Smith S; Black-Grant S; Nichols HB
Cancer Causes Control; 2024 May; 35(5):771-785. PubMed ID: 38175324
[TBL] [Abstract] [Full Text] [Related]
5. Vaginal hysterectomy for the treatment of low-risk endometrial cancer: Surgical technique, costs, and perioperative and oncologic results.
de Souza Nobrega F; Alvarenga-Bezerra V; Barbosa GB; Salim RC; Martins LM; de Cillo PE; de Moura Queiroz P; Moretti-Marques R
Gynecol Oncol; 2024 Feb; 181():76-82. PubMed ID: 38141534
[TBL] [Abstract] [Full Text] [Related]
6. Survival rate of cervical cancer in Asian countries: a systematic review and meta-analysis.
Vali M; Maleki Z; Nikbakht HA; Hassanipour S; Kouhi A; Nazemi S; Hajizade-Valokolaee M; Nayeb M; Ghaem H
BMC Womens Health; 2023 Dec; 23(1):671. PubMed ID: 38098009
[TBL] [Abstract] [Full Text] [Related]
7. Prevalence of Cervical cancer and Clinical Management of Women Screened positive using visual inspection with acetic acid and Cervicography in selected public sector health facilities of Manicaland and Midlands provinces of Zimbabwe, 2021.
Tachiwenyika E; Dhodho M; Muchedzi A; Sibanda TP; Mupanguri C; Mukungunugwa S; Mhangara M; Ganje N; Tapera T; Samushonga T; Muzondo M; Dube S; Tafuma T; Chingombe B; Maravanyika A; Nyamundaya T
PLoS One; 2023; 18(11):e0294115. PubMed ID: 38019889
[TBL] [Abstract] [Full Text] [Related]
8. A Systematic Review of the Effectiveness of Health Education Programs for Cervical cancer Prevention in Rural Communities: Implications for Promoting Health Equity.
Washington A; Smith L; Anderson G; Randall J; Kayser K; LaJoie S
J Cancer Educ; 2024 Apr; 39(2):126-138. PubMed ID: 37996632
[TBL] [Abstract] [Full Text] [Related]
9. Optimising follow-up strategy based on cytology and human papillomavirus after fertility-sparing surgery for early stage cervical cancer: a nationwide, population-based, retrospective cohort study.
Schuurman TN; Schaafsma M; To KH; Verhoef VMJ; Sikorska K; Siebers AG; Wenzel HHB; Bleeker MCG; Roes EM; Zweemer RP; de Vos van Steenwijk PJ; Yigit R; Beltman JJ; Zusterzeel PLM; Lok CAR; Bekkers RLM; Mom CH; van Trommel NE
Lancet Oncol; 2023 Dec; 24(12):1349-1358. PubMed ID: 37952541
[TBL] [Abstract] [Full Text] [Related]
10. Comparing endometrial biopsy results with hysteroscopic pathology in women presenting with abnormal and postmenopausal uterine bleeding.
Ferrando CA; Lintel MK; Bradley LD
J Gynecol Obstet Hum Reprod; 2023 Dec; 52(10):102685. PubMed ID: 37871649
[TBL] [Abstract] [Full Text] [Related]
11. A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancer.
Han SN; Oza A; Colombo N; Oaknin A; Raspagliesi F; Wenham RM; Braicu EI; Jewell A; Makker V; Krell J; Alía EMG; Baurain JF; Su Z; Neuwirth R; Vincent S; Sedarati F; Faller DV; Scambia G
Gynecol Oncol; 2023 Nov; 178():110-118. PubMed ID: 37839313
[TBL] [Abstract] [Full Text] [Related]
12. C-section technique vs minilaparotomy after minimally invasive uterine surgery: a retrospective cohort study.
Della Corte L; Guarino MC; Vitale SG; Angioni S; Mercorio A; Bifulco G; Giampaolino P
Arch Gynecol Obstet; 2024 Jan; 309(1):219-226. PubMed ID: 37796281
[TBL] [Abstract] [Full Text] [Related]
13. Survival benefit of surgery with postoperative radiotherapy in locally advanced cervical adenocarcinoma: a population-based analysis.
Wang X; Lu X; Chen J; Yi H; Lan Q
BMC Surg; 2023 Oct; 23(1):299. PubMed ID: 37789291
[TBL] [Abstract] [Full Text] [Related]
14. Risk of endometrial polyp and surgical intervention in postmenopausal women with proliferative endometrium.
Rotenberg O; Doulaveris G; Fridman D; Renz M; Kaplan J; Xie X; Goldberg GL; Dar P
Maturitas; 2023 Dec; 178():107847. PubMed ID: 37717294
[TBL] [Abstract] [Full Text] [Related]
15. Low-Grade uterine Leiomyosarcoma Is Highly Sensitive to Hormonal Treatment.
Sanfilippo R; Sbaraglia M; Fabbroni C; Croce S; Ray-Coquard I; Guermazi F; Paolini B; Blanc-Durand F; Lecesne A; Chiappa V; Dei Tos AP; Casali PG
Clin Cancer Res; 2023 Nov; 29(22):4679-4684. PubMed ID: 37699075
[TBL] [Abstract] [Full Text] [Related]
16. Opportunities Missed: Cervix cancer Screening Failures in Women Aged 65 and Older.
Ing BI; Scott ME; Lentz SE
J Low Genit Tract Dis; 2023 Oct; 27(4):337-342. PubMed ID: 37467471
[TBL] [Abstract] [Full Text] [Related]
17. Should we abandon hormonal therapy in endometrial cancer? Outcomes of recurrent and metastatic endometrial cancer treated with systemic progestins.
Kulkarni A; Wright NMA; Forget AN; Ramsay T; Mallick R; Weberpals JI
Cancer Med; 2023 Aug; 12(15):16173-16180. PubMed ID: 37417528
[TBL] [Abstract] [Full Text] [Related]
18. Neovaginal Human Papillomavirus Prevalence in Transfeminine Individuals: A Systematic Review.
Nandwana D; Hawes K; Zuend CF; Pope R
Obstet Gynecol; 2023 Aug; 142(2):296-306. PubMed ID: 37411025
[TBL] [Abstract] [Full Text] [Related]
19. Hysteroscopic biopsy compared with endometrial curettage to assess the preoperative rate of atypical hyperplasia underestimating endometrial carcinoma.
Garuti G; Sagrada PF; Frigoli A; Fornaciari O; Finco A; Mirra M; Soligo M
Arch Gynecol Obstet; 2023 Sep; 308(3):971-979. PubMed ID: 37160470
[TBL] [Abstract] [Full Text] [Related]
20. Detection of endometrial cancer using tampon-based collection and methylated DNA markers.
Bakkum-Gamez JN; Sherman ME; Slettedahl SW; Mahoney DW; Lemens MA; Laughlin-Tommaso SK; Hopkins MR; VanOosten A; Shridhar V; Staub JK; Cao X; Foote PH; Clarke MA; Burger KN; Berger CK; O'Connell MC; Doering KA; Podratz KC; DeStephano CC; Schoolmeester JK; Kerr SE; Wentzensen N; Taylor WR; Kisiel JB
Gynecol Oncol; 2023 Jul; 174():11-20. PubMed ID: 37141817
[TBL] [Abstract] [Full Text] [Related]
[Next]
